Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alk-Abello AS has the GF Score of 93, which implies that the company
might have
Highest outperformance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Alk-Abello AS
might have
Highest outperformance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Alk-Abello AS (LTS:0OIR) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Alk-Abello AS GF Score Related Terms
LTS:0OIR vs VRTX, REGN, ALNY: GF Score Comparison
For the Biotechnology subindustry, Alk-Abello AS's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS GF Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's GF Score distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's GF Score falls into.
Alk-Abello AS (LTS:0OIR) has a GF Score of 93 as of Jul. 15, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Alk-Abello AS and its competitors. This is 33% above median its historical median of 70.00. Over the past decade, Alk-Abello AS's GF Score has ranged from 43.00 to 91.00.
Is Alk-Abello AS's GF Score too high?
Alk-Abello AS's current GF Score of 93 is 33% above median its 10-year median of 70.00. Over the past 10 years, this metric has ranged from a low of 43.00 to a high of 91.00. Overall, Alk-Abello AS has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's GF Score compare to VRTX and REGN?
Alk-Abello AS's GF Score of 93 can be compared against companies in the Biotechnology industry. Historically, Alk-Abello AS's own GF Score has ranged from 43.00 to 91.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current GF Score is 93, which is 33% above median its own 10-year median of 70.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (LTS:0OIR) is currently considered Fairly Valued. The stock's GF Value™ is kr151.91, compared to a current price of kr149.45 — trading 1.6% below its estimated fair value. The current GF Score is 93, which is 33% above median its 10-year median of 70.00. Alk-Abello AS's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Alk-Abello AS (LTS:0OIR), the current GF Score is 93 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (LTS:0OIR) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be undervalued.
The current stock price of kr149.45 is trading 1.6% below its estimated GF Value™ of kr151.91.
GuruFocus considers Alk-Abello AS to be Fairly Valued.
Key valuation signals for LTS:0OIR:
GF Score: 93 (33% above median its 10-year median of 70.00)
GF Value™: kr151.91 vs. price of kr149.45 (1.6% below fair value)
No single metric tells the full story. See the LTS:0OIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
93GF Score
Get the complete analysis for LTS:0OIR
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OIR has been successfully added to your 
